Two scientists in full cover interact with a machine in a lab

CREDIT: Cytiva

Bionova Scientific expands capacity and enters advanced therapies market

Cytiva’s Fast Trak process development services will accelerate Bionova’s production processes while ensuring compliance with stringent regulatory standards
| 2 min read

Bionova Scientific, a contract development and manufacturing organization (CDMO), is entering the advanced therapy manufacturing space. The company is installing its third FlexFactory manufacturing platform from Cytiva, a Danaher company and a leader in the life sciences industry, to help meet the surging demand for advanced therapies, while maintaining their core monoclonal antibody (mAb) business. Bionova will also use Cytiva’s Fast Trak process development services to help advance their entry into genomic medicines.

Fabio Fonseca, Ph.D. Senior Director, pDNA Process Development, Bionova Scientific, says: “Using Cytiva’s end-to-end solutions, we’ll have an exceptional platform to support the manufacture of genomic medicines. Together with our team and technology stack, we are well positioned to deliver plasmid DNA with speed, quality and patient safety.”

Ludovic Brellier, President of Hardware Solutions, Cytiva, says: “Our true value lies in our deep process expertise in accelerating our customer’s process development through to commercial manufacturing. Having the flexibility and support to scale while meeting strict regulatory compliance will help Bionova develop a competitive edge in a growing market.”

The FlexFactory platform for advanced therapies offers substantial benefits that reduce business risks, increase operational speed, faster product ramp-up, and enhance flexibility. Its built-in compliance features and robust quality controls helps improve regulatory adherence and minimize production issues, while its modular setup allows rapid adaptation to market shifts. Cytiva’s Fast Trak process development services will help Bionova accelerate their molecule through clinical development.

Bionova’s new facility in The Woodlands, Texas celebrated its grand opening on May 29, 2025, with the new FlexFactory slated for delivery in Q3 2025.

Find more information on the Cytiva FlexFactory manufacturing platform here.

Learn more about Bionova Scientific’s new offerings here.

>Cytiva, the drop logo, FlexFactory and Fast Trak are trademarks of Global Life Sciences Solutions USA LLC or an affiliate doing business as Cytiva.

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
3D illustration of RNA molecules on a gradient blue background.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue